Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-25-283019
Filing Date
2025-11-14
Accepted
2025-11-14 16:17:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14437
  Complete submission text file 0001193125-25-283019.txt   16158
Mailing Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025
Business Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners IV, LLC (Filed by) CIK: 0001829169 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94231 | Film No.: 251486584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)